System for occlusion of left atrial appendage

ABSTRACT

A device for occluding an atrial appendage includes a catheter-deliverable epicardial implant that is detachably secured to a delivery device. The implant includes an inflatable cuff that is positionable about the atrial appendage to an extent that, when adjustably inflated, the cuff physiologically occludes the atrial appendage. Such occlusion addresses health risks associated with atrial fibrillation and cardiac rhythm disorder.

CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No.14/809,473, filed on Jul. 27, 2015 and entitled “System for Occlusion ofLeft Atrial Appendage”, which is a continuation of U.S. patentapplication Ser. No. 13/168,009, filed on Jun. 24, 2011 and entitled“System for Occlusion of Left Atrial Appendage”, which itself claimspriority to U.S. Provisional Application Ser. No. 61/358,127, filed onJun. 24, 2010 and entitled System for Occlusion of Left AtrialAppendage”, the contents of which are being incorporated herein in theirentirety.

FIELD OF THE INVENTION

The present invention relates to devices and methods for occludinglumens in internal soft body tissue, and more particularly to devicesand methods for physiologically occluding the left atrial appendage(“LAA”). The present invention involves a permanent or semi-permanentimplant which epicardially occludes the LAA, and is adjustable so as toocclude the LAA from its base.

BACKGROUND OF THE INVENTION

Atrial fibrillation (“AF”) is a common cardiac rhythm disorder (“cardiacarrhythmia”) and is characterized by a rapid chaotic heartbeat in whichthe upper chambers of the heart known as the atria quiver rapidlyinstead of beating in a steady rhythm. This rapid quivering reduces theheart's ability to properly function as a pump.

Atrial fibrillation typically increases the risks of thrombo-embolicstroke and congestive heart failure. Quality of life is also impaired bycommon AF symptoms such as palpitations, chest pain, fatigue, anddizziness. The irregular heartbeat associated with AF causes blood topool in the left atrial appendage, allowing clots to accumulate overtime. From time to time, clots may dislodge from the left atrialappendage, and may enter various circulation tracks causing strokes,myocardial infarction, limb ischemia, and other vascular problems.

A number of approaches have been implemented to address the health risksassociated with AF. Among such techniques, surgical procedures forclosing (occluding) the left atrial appendage (LAA) have been proposed.Some of such procedures involve open chest wall midstemotomy procedureswhile others may access the pericardial space through a thoracotomy orfrom a sub-xiphoid access point. In such approaches, a physical deviceis typically employed to cinch or compress the LAA.

Conventional LAA closure devices, however, are difficult to preciselyposition at the LAA, and therefore result in incomplete occlusion of theLAA, as the surgical closure point is oftentimes spaced from the base ofthe LAA. Moreover, conventional closure devices lack simplerepositioning and adjustment capabilities, such that attempts tophysiologically completely occlude the LAA frequently fail.

It is therefore an object of the invention to provide a tissue occlusiondevice which facilitates placement and ultimate closure of the leftatrial appendage at its base.

It is another object of the present invention to provide an atrialappendage closure device having adjustment capabilities to facilitatere-positioning of the device at the atrial appendage, and completeocclusion of the appendage at its base.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a schematic diagram of an atrial appendage occlusion device ofthe present invention;

FIG. 2 is an isolation view of a portion of the atrial appendageocclusion device illustrated in FIG. 1;

FIG. 2A is a top schematic view of a portion of the atrial appendageocclusion device illustrated in FIGS. 1 and 2 in an open condition;

FIG. 2B is a top schematic view of a portion of the atrial appendageocclusion device illustrated in FIGS. 1 and 2 in a closed condition;

FIG. 3 is a schematic diagram of an atrial appendage occlusion device ofthe present invention engaged with a left atrial appendage;

FIG. 3A is a schematic view of an atrial appendage occlusion deviceengaged with a left atrial appendage in an open condition;

FIG. 3B is a schematic view of an atrial appendage occlusion deviceengaged with a left atrial appendage in a closed condition;

FIG. 4A is an isolation view of a portion of the atrial appendageocclusion device illustrated in FIGS. 1 and 2 in an open condition;

FIG. 4B is an isolation view of a portion of the atrial appendageocclusion device illustrated in FIGS. 1 and 2 in a closed condition;

FIG. 5A is an isolation elevational view of a portion of the atrialappendage occlusion device illustrated in FIGS. 1 and 2;

FIG. 5B is a schematic view of an atrial appendage occlusion device inengagement with a left atrial appendage;

FIG. 5C is a schematic view of an atrial appendage occlusion device inengagement with a left atrial appendage;

FIG. 5D is a schematic view of an atrial appendage occlusion device inengagement with a left atrial appendage in a closed condition;

FIG. 5E is a schematic view of an atrial appendage occlusion device inocclusive engagement with a left atrial appendage; and

FIG. 5F is a schematic view of an atrial appendage occlusion device withan implant portion separated from a delivery device.

DESCRIPTION OF THE INVENTION

The objects and advantages enumerated above together with other objects,features, and advances represented by the present invention will now bepresented in terms of detailed embodiments described with reference tothe attached drawing figures which are intended to be representative ofvarious embodiments of the invention. Other embodiments and aspects ofthe invention are recognized as being within the grasp of those havingordinary skill in the art.

With reference now to the drawings, and first to FIG. 1, an atrialappendage occlusion device 10 includes a multiple lumen delivery device12, such as a steerable catheter, as is well known in the art. In oneembodiment, delivery device 12 includes first and second lumens 14, 16for simultaneously delivering a plurality of devices to, for example,the left atrial appendage (LAA) 20 of a left atrium 22 of a human heart.In the illustrated embodiment, a grasping device 18 may be deliveredthrough first lumen 14, while an implant 24 may be delivered throughsecond lumen 16 of delivery device 12.

One aspect of the present invention provides forlaparoscopic/percutaneous transport of delivery device 12 to LAA 20. Insome embodiments, delivery device 12 is a distally steerable catheterfor minimally invasive introduction to the pericardial space through thepleural or sub-xiphoid spaces using a seldinger technique. In such amanner, implant 24 of the present invention may be delivered to the LAAwithout the need for midsternotomy. It is to be understood, however,that the device 10 of the present invention may be useful for directaccess to the LAA in cases where the patient is undergoing amidsternotomy for other surgical procedures. In either scenario, device10 is arranged for an epicardial treatment of the LAA.

Once device 10 has been introduced into the patient, advancement andpositioning may be performed through conventional imaging techniques,such as thoracoscopic or fluoroscopic imaging. In some embodiments,delivery device 12 may be compatible with imaging scopes which may beintroduced through a selected lumen 14, 16 thereof.

As described above, the device of the present invention is arranged toocclude, for example, LAA 20 by pinching, cinching, crimping, clamping,compressing, or otherwise closing base 26 of LAA 20. In one embodiment,closing or “occluding” LAA 20 at base 26 is accomplished by securing aninner surface 28 of LAA 20 to itself substantially at base 26. Suchsecurement effectively fluidly seals off an interior of LAA 20 from leftatrium 22, and prevents blood clots from embolizing from within LAA 20to left atrium 22. In some embodiments, the occlusion is of a characterto cut off nutrient-providing blood supply to the tissue of LAA 20,thereby eventually resulting in necrosis and/or obliteration of LAA 20.In the illustrated embodiment, a means for effectuating occlusion of LAA20 is implant 24, which may be detachably secured to delivery device 12to remain indefinitely after delivery device 12 is removed from thepatient.

In the embodiment illustrated in FIG. 1, a grasping device 18 may beemployed to grasp and releasably hold LAA 20 to facilitate positioningand engagement of implant 24 at LAA 20. Grasping device 18 may typicallycomprise a conventional grasping tool, such as a suction tube whichestablishes negative pressure at a distal end 19 thereof, the negativepressure being suitable to releasably retain tissue, such as LAA 20 atdistal end 19. Alternative grasping tools include thoracoscopic forcepsand the like.

An enlarged view of implant 24 is illustrated in FIG. 2, wherein implant24 includes a clamp 32 and an inflatable cuff 34 attached to clamp 32.In some embodiments, clamp 32 is selectively adjustable between an open,unclamped condition 36 (as illustrated in FIG. 2), and a closed, clampedposition 38. Applicant contemplates a variety of mechanisms forselectively adjusting clamp 22 between the open and closed conditions36, 38. For example, implant 24 may utilize a control arm 40, whichincorporates the dual purpose of physically manipulating the spatialposition of clamp 32, as well as selectively adjusting clamp 32 betweenopen and closed conditions 36, 38. An example mechanism for effectuatingsuch selective adjustment is illustrated in FIGS. 2A and 2B. In theillustrated embodiment, control arm 40 includes actuators 42, 44, whichare detachably secured to clamp 32 at securement points 46. First andsecond actuators 42, 44 may be proximally controlled to move relative toone another generally along directions 48, 50 so as to adjust clamp 32between open and closed conditions 36, 38. First and second actuators42, 44 are also capable of rotating clamp 32 about an axis 52, and forturning clamp 32 into alignment with LAA 20. Such alignment enablesfirst and second prongs 60, 62 to be placed at least partially about LAA20.

In addition to, or in place of, the detachable securement of first andsecond actuators 42, 44 at securemented points 46, control arm 40 mayinclude a detachable link 54 which may be severed, opened, or otherwisereleased so as to disengage clamp 32 from control arm 40. Applicantcontemplates a variety of mechanisms for detachably securing clamp 32 tocontrol arm 40, with some of such mechanisms being conventionallyunderstood by those of ordinary skill in the art.

As indicated above, implant 24 may be positioned at LAA 20 throughthoracoscopic or fluoroscopic guidance. FIG. 3 illustrates an engagementof implant 24 with LAA 20. Implant 24 may be manipulated by, forexample, first and second actuators 42, 44, so that first and secondprongs 60, 62 of clamp 32 are positioned at substantially opposed sides68, 70 of LAA 20, and about at least a portion of LAA 20.

As illustrated in the schematic views of FIGS. 3A and 3B, LAA 20includes a lumen 21 defined by inner surface 28. Implant 24 is engagedwith LAA 20 initially while in an open condition 36, with first andsecond prongs 60, 62 of clamp 32 being positioned at substantiallyopposed sides 68, 70 of LAA 20. When clamp 32 is manipulated asdescribed above from open condition 36 to closed condition 38, asillustrated in FIG. 3B, lumen 21 of LAA 20 may be substantially closedthrough the pressing together of opposed sides 68, 70 of LAA 20 to anextent that inner surface 28 is in contact with itself. The placement ofclamp 32 in closed condition 38 may occlude LAA 20 by completely closinglumen 21. However, as described in greater detail hereinbelow, clamp 32primarily serves as an anchoring element for inflatable cuff 34, suchthat inflatable cuff 34 is positioned and oriented to physiologicallyocclude LAA 20 at base 26.

In one aspect of the present invention, clamp 32 may be selectivelyadjusted between open and closed positions 36, 38 to not only anchorimplant 24 at LAA 20, but to also facilitate the repositioning ofimplant 24 at LAA 20. For example, imaging techniques such asfluoroscopy and echocardiography may be utilized to assess whetherinflatable cuff 34 is properly positioned to physiologically occlude LAA20 at base 26. In the event that it is determined that the initialplacement of implant 24 is incorrect for a preferred occlusion of LAA20, an adjustment mechanism, such as first and second actuators 42, 44of control arm 40 may reopen clamp 32 from closed condition 38 to opencondition 36, and thereafter reposition clamp 32 at LAA 20. Once theposition of clamp 32 (and implant 24) has been adjusted, clamp 32 mayagain be modified from open condition 36 to closed condition 38 tosecurely anchor implant 24 at LAA 20. Such adjustability of clamp 32,and correspondingly implant 24, is facilitated through the detachableconnection of control arm 40 to clamp 32. The detachable connection, asdescribed above, enables proximal control to repeatedly adjust clamp 32between open and closed conditions 36, 38, including from open condition36 to closed condition 38, and from closed condition 38 to opencondition 36. Such adjustment of clamp 32 may be repeated several timesif necessary to appropriately position and orient implant 24 at LAA 20.

Clamp 32 may be fabricated from a variety of biocompatible materials,such as stainless steel, titanium, and other metallic, alloy, andnon-metallic materials. In some embodiments, clamp 32 may be formed of aresilient material, thereby continuing to apply direct pressure to LAA20 enclosed within clamp 32 in closed condition 28. Because clamp 32primarily serves as an anchoring device, clamp 32 need not be ofspecific structural capacity, and may therefore exhibit a relatively lowprofile for ease of delivery and placement at LAA 20.

As illustrated in FIGS. 4A and 4B, clamp 32 includes first and secondprongs 60, 62 emanating from central portion 61. First and second prongs60, 62 may be the same or different curvatures forming various shapes,including an opening with tapered ends, oval, ovoid, crescent, etc.Prong length “L” may be equal or different as between first and secondprongs 60, 62, and may be provided in various sizes as physiologicallyappropriate. For example, prong length “L” may be between about 1-5 cm,though other sizes are contemplated as being useful in the presentinvention. Moreover, prong thickness “T” may be even or uneven alongfirst and second prongs 60, 62, and may be between, for example, about0.1-5 mm.

Clamp 32 may also include tissue engaging projections and fasteners,such as spikes, staples, rivets, sutures, and clips extending from oneor both of first and second prongs 60, 62. The tissue fasteners may beformed of a resilient, elastic, superelastic, metallic, alloy, ornon-metallic material. The tissue fasteners may be integrally formedwith clamp 32, mounted within clamp 32, or mounted within a device thatmay be attached to clamp 32.

The repositionability of clamp 32 is advantageous for preciselypositioning inflatable cuff 34 at LAA 20, such that inflation of cuff 34physiologically occludes LAA 20 at base 26. For the purposes hereof, theterm “physiologically occludes” is intended to mean the substantiallycomplete closure or occlusion of lumen 21 of LAA 20 to an extentappropriate to prevent the formation of clot and the release of embolifrom the appendage. Therefore, “physiological occlusion” may include anyclosure of LAA 20 which is effective in the prevention of clot formationand the release of emboli therefrom, and need not comprise the closureof the entirety of lumen 21 of LAA 20. In some embodiments,“physiologically occludes” may refer to a closure of lumen 21 at or nearbase 26 with such closure constituting intimate contact of inner surface28 at or near base 26 to an extent appropriate to prevent blood flowinto and out from LAA 20.

Inflatable cuff 34 includes one or more portions 70A, 70B that may beselectively inflated with a fluid, such as saline, to inwardly pressupon LAA 20 to an extent appropriate to physiologically occlude LAA 20.To selectively inflate inflatable cuff 34, implant 24 includes a fluidsupply tube 78 that is detachably secured to inflatable cuff 34. Fluidsupply tube 78 may be configured for selectively conveying pressurizedfluid such as saline to inflatable cuff 34 through a one way valve 80which permits fluid flow into, but not out from, inflatable cuff 34.Fluid supply tube 78 is preferably deliverable along with implant 24through a lumen 16 of delivery device 12.

In some embodiments, inflatable cuff 34 defines one or more balloonstructures defining respective portions 70A, 70B, with the balloonstructures employing a resiliently elastic skin which may be resilientlyexpanded upon inflating fluid flow from fluid supply tube 78 intorespective chambers thereof. As illustrated in FIG. 5A, inflatable cuff34 may include relatively rigid outer walls 35 with relatively elasticand non-rigid inner walls 37. In such a manner, inflation of inflatablecuff 34 causes expansion of inflatable cuff 34 inwardly along directionarrows 39. Such inward expansion of inflatable cuff 34 effectuates theocclusion of LAA 20.

Inflatable cuff 34 may be fabricated from a variety of materials toprovide the functionality described above. In particular, inflatablecuff 34 may include a skin layer 82 which is manufactured from one ormore materials to provide zoned characteristics. As described above, afirst material for skin layer 82 may be substantially rigid at outersurface 35, while a different material may be provided at an innersurface 37. In other embodiments, reinforcement materials or devices maybe employed to promote inward expansion of cuff 34 upon inflationthereof. Such reinforcement materials or devices may be disposed at oradjacent to outer surface 35 of inflatable cuff 34 to limitoutwardly-directed expansion.

Inflatable cuff 34 may be secured to clamp 32 at one or more pointsalong clamp 32. In some embodiments, inflatable cuff 34 is secured tothe entire length of clamp 32. In other embodiments, however, inflatablecuff 34 may extend only partially along clamp 32, and may includediscontinuous portions along clamp 32. A variety of securementmechanisms are contemplated by the present invention to secureinflatable cuff 34 to clamp 32. Example mechanisms include adhesives,fasteners, and other mechanisms, including conventional mechanisms forsecuring inflatable cuff 34 to clamp 32.

Inflatable cuff 34 may include one or more distinct chambers that aresequentially or simultaneously filled with inflation fluid suppliedthrough fluid supply tube 78. In one embodiment, for example, inflatablecuff 34 may include a plurality of chambers which are filled through an“overflow” concept in which a secondary chamber is filled only after aprimary chamber is completely filled with fluid. In some embodiments,each portion 70A, 70B of inflatable cuff 34 may be filled with betweenabout 1-10 cc of fluid.

An occlusion sequence utilizing implant 24 is illustrated in FIGS.5B-5E, in which implant 24 is placed about LAA 20 in an open condition36. Positioning of implant 24 at LAA 20 may be verified throughechocardiography and fluoroscopy. FIG. 5B illustrates an improperpositioning of implant 24, in that inflatable cuff 34 does not extend tobase 26 of LAA 20, where occlusion is desired. In one embodiment, clamp32 may be adjusted to a closed condition 38 at the position illustratedin FIG. 5B, followed by position verification through echocardiographyand/or fluoroscopy. When it is determined that the position and/ororientation of implant 24 is incorrect, clamp 32 may be re-adjusted toan open condition 36 for re-positioning of implant 24, as describedabove.

Implant 24 may be re-positioned, as illustrated in FIG. 5C. Here,inflatable cuff 34 extends substantially to base 26 of LAA 20.Confirmation of such appropriate position and orientation may beperformed, for example, subsequent to adjustment of clamp 32 to a closedcondition 38, such as is illustrated in FIG. 5D.

Once the appropriate position of implant 24 has been confirmed, fluid isdirected through fluid supply tube 78, and through one-way valve 80 intoinflatable cuff 34 to thereby expand inflatable cuff 34 to an extentappropriate to physiologically occlude LAA 20 at base 26. FIG. 5Eillustrates such occlusion subsequent to inflation of inflatable cuff34. Sufficient occlusion of LAA 20 may be confirmed throughechocardiography and/or fluoroscopy. If, for example, further closure ofLAA 20 is required to accomplish physiological occlusion, additionalfluid may be added to inflatable cuff 34 through fluid supply tube 78.

Once appropriate occlusion has been confirmed, control arm 40 may bedetached from clamp 32 as described above. Moreover, fluid supply tube78 may be separated from inflatable cuff 34, preferably upstream fromone-way valve 80 so as to maintain fluid pressure within inflatable cuff34. An illustration of implant 24 at LAA 20 subsequent to separationfrom control arm 40 and fluid supply tube 78 is shown in FIG. 5F. Avariety of mechanisms are contemplated for separating fluid supply tube78 from inflatable cuff 34. In one embodiment, a thoracoscopic scissormay be guided through delivery device 12 to cut fluid supply tube 78 ata location proximal to one-way valve 80. Subsequent to the separation,the thoracoscopic scissor, fluid supply tube 78, and control arm 40 maybe withdrawn through respective lumens 14, 16 of delivery device 12, andthe delivery device 12 may thereafter be withdrawn from the patient.Consequently, implant 24 may be left at LAA 20 indefinitely to ensurephysiological occlusion thereof.

In one embodiment, inflatable cuff 34 is detachably secured to clamp 32,such that subsequent to confirmation of physiological occlusion of LAA20 by inflatable cuff 34, clamp 32 may be detached from inflatable cuff34, and withdrawn from the procedure site through delivery device 12. Insuch an embodiment, only inflatable cuff 34 is left at LAA 20 followingthe occlusion procedure. Therefore, it is to be understood that clamp 32primarily acts as an anchoring mechanism, while inflatable cuff 34performs the occlusion of LAA 20. Inflatable cuff 34 may assume avariety of configurations, and in one embodiment may have a height “H”of about 0.2-2 cm. Other sizes, however, of inflatable cuff 34 may beemployed in implant 24 of the present invention.

For the purposes hereof, the term “cuff” is not intended to be exclusiveof the various inflatable or otherwise expandable bodies useful in thepresent application. To that end, other terms may be interchangeablyutilized to describe inflatable cuff 34. Example alternative termsinclude bladder, balloon, diaphragm, vessel, skirt, tube, and the like.Moreover, inflatable cuff 34 may be selectively and adjustablyexpandable through means other than inflation, including variousmechanical expansion means to constrict the LAA 20 to an occlusiveextent.

The invention has been described herein in considerable detail in orderto comply with the patent statutes, and to provide those skilled in theark with the information needed to apply the novel principles and toconstruct and use embodiments of the invention as required. However, itis to be understood that the invention can be carried out by differentmethods/devices, and that various modifications can be accomplishedwithout departing from the scope of the invention itself.

What is claimed is:
 1. An epicardial implant, comprising: a positioningdevice defining an open interior having a central axis, wherein thepositioning device is configured to be detachably coupled with animplant delivery device such that the positioning device may be detachedfrom the implant delivery device after the epicardial implant is inplace about the atrial appendage, and wherein the open interior of thepositioning device receives a portion of the atrial appendage; and atleast one expandable cuff coupled with the positioning device such thatthe at least one expandable cuff is positioned outside of the openinterior of the positioning device; wherein the positioning device isconfigured to selectively move the expandable cuff toward and away froman atrial appendage to position the expandable cuff in a desiredposition relative to the atrial appendage; wherein the at least oneexpandable cuff is expandable inwardly toward the central axis of theopen interior of the positioning device following placement of theexpandable cuff into the desired position; and wherein the at least oneexpandable cuff is configured to physically occlude a base of the atrialappendage when expanded.
 2. The epicardial implant of claim 1, wherein:the positioning device comprises a first prong that is coupled with asecond prong at a hinge that is configured to adjust a distance betweenthe first prong and the second prong, wherein a space between the firstprong and the second prong defines the open interior of the positioningdevice.
 3. The epicardial implant of claim 1, wherein: the at least oneexpandable cuff comprises a plurality of distinct chambers that aresequentially or simultaneously filled with a fluid to expand the atleast one expandable cuff.
 4. The epicardial implant of claim 3,wherein: the fluid comprises saline.
 5. The epicardial implant of claim1, wherein: the at least one expandable cuff comprises at least onerigid outer wall and at least one elastic and non-rigid inner wall. 6.The epicardial implant of claim 1, further comprising: a one-way valvethat is configured to allow fluid to enter an interior of the at leastone expandable cuff to expand the at least one expandable cuff.
 7. Theepicardial implant of claim 1, wherein: the at least one expandable cuffcomprises an inflatable balloon.
 8. An epicardial implant, comprising: apositioning device defining an open interior between a first prong and asecond prong, the open interior having a central axis, wherein the firstprong and the second prong are movable between an open position and aclosed position, wherein the positioning device is configured to bereleasably coupled with an implant delivery device, and wherein the openinterior of the positioning device receives a portion of the atrialappendage: at least one expandable cuff that is coupled with thepositioning device such that the at least one expandable cuff ispositioned outside of the open interior of the positioning device andthat is expandable inwardly toward the central axis of the open interiorof the positioning device, wherein the at least one expandable cuff isconfigured to physically occlude a base of an atrial appendage whenexpanded; and a one-way valve that is configured to allow fluid to enteran interior of the at least one expandable cuff to expand the at leastone expandable cuff.
 9. The epicardial implant of claim 8, wherein: theat least one expandable cuff comprises a first expandable cuff that iscoupled with the first prong and a second expandable cuff that iscoupled with the second prong.
 10. The epicardial implant of claim 8,wherein: the at least one expandable cuff comprises at least one rigidouter wall and at least one elastic and non-rigid inner wall.
 11. Theepicardial implant of claim 8, wherein: the at least one expandable cuffcomprises an inflatable balloon.
 12. The epicardial implant of claim 8,wherein: the one-way valve is configured to be detachably coupled with afluid supply tube of a delivery device.
 13. The epicardial implant ofclaim 8, wherein: the positioning device is repeatedly manipulatablebetween the open position and the closed position such that thepositioning device is repositionable relative to the atrial appendage.14. The epicardial implant of claim 8, wherein the positioning devicefurther comprises: one or more tissue engaging features.
 15. A methodfor treating an atrial appendage, the method comprising: providing anepicardial implant, the epicardial implant comprising: a positioningdevice defining an open interior having a central axis; and at least oneexpandable cuff that is coupled with the positioning device such thatthe at least one expandable cuff is positioned outside of the openinterior of the positioning device and that is expandable inwardlytoward the central axis of the open interior of the positioning device;positioning the epicardial implant around an external surface of theatrial appendage such that a base of the atrial appendage is disposed inthe open interior of the positioning device; and expanding the at leastone expandable cuff inwardly toward the central axis of the openinterior of the positioning device to an extent sufficient to physicallyocclude the atrial appendage at the base.
 16. The method for treating anatrial appendage of claim 15, wherein: expanding the at least oneexpandable cuff comprises introducing a fluid into an interior of the atleast one expandable cuff via a fluid supply tube.
 17. The method fortreating an atrial appendage of claim 16, wherein: the fluid isintroduced into the at least one expandable cuff via a one-way valvethat interfaces with the fluid supply tube.
 18. The method for treatingan atrial appendage of claim 15, wherein: positioning the epicardialimplant comprises closing the positioning device around the base of theatrial appendage such that the base of the atrial appendage is anchoredwithin the open interior of the positioning device.
 19. The method fortreating an atrial appendage of claim 15, further comprising: uponexpanding the at least one expandable cuff, disengaging the epicardialimplant from a delivery device.
 20. The method for treating an atrialappendage of claim 15, further comprising: prior to positioning theepicardial implant, grasping the atrial appendage using a graspingdevice of a delivery device.